Insider Transactions Reported by 23 Insiders of REGENERON PHARMACEUTICALS, INC.

Symbol
REGN on Nasdaq
Location
Tarrytown, NY

Insiders trading volume in the past year

REGENERON PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
GEORGE YANCOPOULOS Bd. Co-Chair, President & CSO, Director $784,544,713 09 Dec 2025
LEONARD S. SCHLEIFER Bd. Co-Chair, President & CEO, Director $479,538,604 09 Dec 2025
VAGELOS P ROY Director $444,337,350 03 Apr 2023
NEIL STAHL EVP Research and Development $43,324,609 16 Dec 2024
ANDREW MURPHY EVP Research $36,595,908 09 Dec 2025
JOSEPH LAROSA EVP General Counsel and Secret $29,938,330 05 Dec 2025
Daniel P. Van Plew EVP & General Mgr, Industrial $24,589,665 09 Dec 2025
Robert E. Landry EVP Finance CFO $22,918,280 02 Feb 2024
GEORGE L. SING Director $21,230,120 31 Dec 2024
Christopher R. Fenimore EVP Finance CFO $15,475,790 05 Dec 2025
ARTHUR F. RYAN Director $12,568,956 02 Jan 2025
Marion McCourt EVP Commercial $10,202,879 09 Dec 2025
MICHAEL S. BROWN Director $9,001,095 02 Jan 2025
JOSEPH L. GOLDSTEIN Director $4,637,228 02 Jan 2025
Jason Pitofsky VP Controller $3,930,232 -$280,766 -6.7% 05 Dec 2025
CHRISTINE A. POON Director $2,633,330 -$4,252,745 -61.8% 29 Oct 2025
Marc Tessier-Lavigne Director $2,315,367 03 Jan 2023
Bonnie L. Bassler Director $1,161,000 -$570,000 -32.9% 20 Nov 2025
N. ANTHONY COLES Director $1,104,068 02 Jan 2025
Huda Y. Zoghbi Director $1,096,278 02 Jan 2025
Craig B. Thompson Director $439,078 02 Jan 2025
David P. Schenkein Director $317,269 02 Jan 2025
Kathryn Guarini Director $317,269 02 Jan 2025

Recent Insider Transactions by Companies or Individuals for REGENERON PHARMACEUTICALS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.